Professor and Dept. of Rad. Onc. Chair Mayo Clinic Arizona
Radiation Oncology
Dr. Steven E. Schild, MD
|
|
Give Review
Steven Schild is an expert in the field of Radiation Oncology. He researched medicine at Creighton University School of Medicine. Creighton University School of Medicine is ranked 79/78 in Research/PrimaryCare. He has 20 awards "America's Top Doctors", "Top Doctors:Arizona State", "America's Top Doctors for Cancer", "Mayo Clinic Investigator of the Year Award", "Distinguished Service Award", "Best Doctors in America", "Editor's Recognition Award", "Award for Best of Session, Poster Presentation", "Valedictorian Class of 1985", "Deans List, Six Semesters", "Superior Scholastic Achievement Award", "Lange Medical Publications Student Award, 2 Years", "Mosby Scholarship Book Award", "Adolf Sachs Award, Highest Cumulative Average", "Irving Bernstein Award in Physiology", "School of Medicine Scholarship, 2 Years", "Merck Manual Award", "Alpha Omega Alpha Medical Society", "Clinical Oncology Fellowship in Radiation Oncology" and "Superior Scholastic Achievement Award For 2 years". Doctor Steven E. Schild, MD is also published. He has 101 publications published. The lastest publication: "RE: Prevalence and Predictors of Inappropriate Delivery of Palliative Thoracic Radiotherapy for Metastatic Lung Cancer.' He accepts Medicare.
Publications
- Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Ch...
- RE: Prevalence and Predictors of Inappropriate Delivery of Palliative Thoracic Radiotherapy for Metastatic Lung Cancer.
- A Tool to Estimate Survival of Elderly Patients Presenting with Metastatic Epidural Spinal Cord Compression (MESCC) from Cancer of Unknown Primary.
- Metastatic Spinal Cord Compression: A Survival Score Particularly Developed for Elderly Prostate Cancer Patients.
- A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Canc...
- Proposed prognostic scoring system evaluating risk factors for biochemical recurrence of prostate cancer after salvage radiation therapy.
- Single-Fraction Versus 5-Fraction Radiation Therapy for Metastatic Epidural Spinal Cord Compression in Patients With Limited Survival Prognoses: Results of a Matched-P...
- Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage I...
- Prophylactic cranial irradiation in elderly patients with small cell lung cancer: Findings from a North Central Cancer Treatment Group pooled analysis.
- Early Outcome of Prostate Intensity Modulated Radiation Therapy (IMRT) Incorporating a Simultaneous Intra-Prostatic MRI Directed Boost.
- Comparison of Two Dose Levels of Stereotactic Radiosurgery for 1-3 Brain Metastases from Non-small Cell Lung Cancer.
- Impact of respiratory motion on worst-case scenario optimized intensity modulated proton therapy for lung cancers.
- Proton beam therapy for locally advanced lung cancer: A review.
- Radiosurgery Alone for 1-3 Newly-diagnosed Brain Metastases from Melanoma: Impact of Dose on Treatment Outcomes.
- A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin and Concurrent Thoracic Radiation Therapy for Non-Small Cell Lung Cancer: NCCTG-N0321.
- Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis.
- Six-year Outcome of a Prospective Study Evaluating Tumor Bed Boost with Intra-operative Electron Irradiation Followed by whole-Breast Irradiation for Early-Stage Breas...
- Lack of Association between COX-2 Staining Level and Biochemical Recurrence Following Salvage Radiation Therapy for Recurrent Prostate Cancer.
- Charged particle radiation therapy for uveal melanoma: a systematic review and meta-analysis.
- Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
- Re: Proton vs Intensity-Modulated Radiotherapy for Prostate Cancer: Patterns of Care and Early Toxicity.
- Nine-Year Outcome and Toxicity in Patients treated with IMRT for Localized Prostate Cancer.
- A Randomized Phase II Study of Gemcitabine and Carboplatin with or without Cediranib as First-Line Therapy in Advanced Non-Small-Cell Lung Cancer: North Central Cancer...
- Dose-escalation of whole-brain radiotherapy for brain metastasis in patients with a favorable survival prognosis.
- Malignant epidural spinal cord compression: the role of external beam radiotherapy.
- Single brain metastasis: Resection followed by whole-brain irradiation and a boost to the metastatic site compared to whole-brain irradiation plus radiosurgery.
- Dose escalation of radiotherapy for Metastatic Spinal Cord Compression (MSCC) in patients with relatively favorable survival prognosis.
- Single brain metastasis: Radiosurgery alone compared with radiosurgery plus up-front whole-brain radiotherapy.
- Prognostic Factors (Including HPV Status) for Irradiation of Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN).
- Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III/IV squamous cell carcinoma of the head and neck : A matched-pair...
- Single brain metastasis: Whole-brain irradiation plus either radiosurgery or neurosurgical resection.
- Radiochemotherapy versus surgery plus radio(chemo)therapy for stage T3/T4 larynx and hypopharynx cancer - Results of a matched-pair analysis.
- The prognostic impact of tumor cell expression of estrogen receptor-?, progesterone receptor, and androgen receptor in patients irradiated for non-small cell lung cancer.
- Image-Guided Radiotherapy for Prostate Cancer: A Prospective Trial of Concomitant Boost Using Indium-111-Capromab Pendetide (ProstaScint) Imaging.
- Shorter-course Whole-brain Radiotherapy for Brain Metastases in Elderly Patients.
- Evaluation of B7-H3 expression as a biomarker of biochemical recurrence after salvage radiation therapy for recurrent prostate cancer.
- Validation of a score predicting post-treatment ambulatory status after radiotherapy for metastatic spinal cord compression.
- Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of ...
- Surgery Followed by Radiotherapy Versus Radiotherapy Alone for Metastatic Spinal Cord Compression from Unfavorable Tumors.
- Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-...
- Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation...
- A front-line window of opportunity phase 2 study of sorafenib in patients with advanced nonsmall cell lung cancer: North Central Cancer Treatment Group Study N0326.
- Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression.
- Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy?
- Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis.
- Fibroblast Growth Factor 2-A Predictor of Outcome for Patients Irradiated for Stage II-III Non-Small-Cell Lung Cancer.
- A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422).
- Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose?
- Hypofractionated whole-brain radiotherapy for multiple brain metastases from transitional cell carcinoma of the bladder.
- Radiolabeled cetuximab plus whole-brain irradiation (WBI) for the treatment of brain metastases from non-small cell lung cancer (NSCLC).
- Correlation between polymorphisms of the reduced folate carrier gene (SLC19A1) and survival after pemetrexed-based therapy in non-small cell lung cancer: a North Centr...
- Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression.
- Validation and simplification of a score predicting survival in patients irradiated for metastatic spinal cord compression.
- Prognostic Impact of Erythropoietin Expression and Erythropoietin Receptor Expression on Locoregional Control and Survival of Patients Irradiated for Stage II/III Non-...
- Comparison of Four Cisplatin-Based Radiochemotherapy Regimens for Nonmetastatic Stage III/IV Squamous Cell Carcinoma of the Head and Neck.
- Scoring Systems to Estimate Intracerebral Control and Survival Rates of Patients Irradiated for Brain Metastases.
- Dose Escalation for Metastatic Spinal Cord Compression in Patients with Relatively Radioresistant Tumors.
- Acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN): a matched pair ...
- Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC).
- Dose escalation of whole-brain radiotherapy for brain metastases from melanoma.
- Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors.
- Treatment of painful bone metastases.
- Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC).
- Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis.
- Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer.
- Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.
- The role of postoperative radiotherapy for the treatment of gangliogliomas.
- Endpoints in phase II trials for advanced non-small cell lung cancer.
- Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy.
- Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer.
- Radioactive EGFR antibody cetuximab in multimodal cancer treatment: stability and synergistic effects with radiotherapy.
- Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck.
- Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer.
- Prognostic factors for survival and intracerebral control after irradiation for brain metastases from gynecological cancer.
- Prostate brachytherapy seed embolization to the right renal artery.
- Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.
- Role of radiation therapy in the treatment of melanoma.
- A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic si...
- Metastatic malignant melanoma.
- Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1-3 brain metastases: results of a matche...
- p53 Mutations in carcinoma of the esophagus and gastroesophageal junction.
- Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases.
- Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long-course radiotherapy for local control of malign...
- Comparison of different treatment approaches for one to two brain metastases in elderly patients.
- A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression.
- Impact of VEGF and VEGF receptor 1 (FLT1) expression on the prognosis of stage III esophageal cancer patients after radiochemotherapy.
- Elective Nodal Irradiation (ENI) doesn't appear to provide a clear benefit for patients with unresectable non-small-cell lung cancer (NSCLC).
- Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression.
- Malignant melanoma in the 21st century: the emerging molecular landscape.
- Effect of smoking during radiotherapy, respiratory insufficiency, and hemoglobin levels on outcome in patients irradiated for non-small-cell lung cancer.
- Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.
- A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
- The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation.
- Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for lo...
- Surgical resection followed by whole brain radiotherapy versus whole brain radiotherapy alone for single brain metastasis.
- A comparison of chemotherapy plus surgery with surgery alone for localized esophageal cancer.
- Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin.
- Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy.
- Cisplatin alone or in combination versus hydroxyurea during pelvic irradiation for cervical cancer.
- Toxicity of two cisplatin-based radiochemotherapy regimens for the treatment of patients with stage III/IV head and neck cancer.
Schools
Creighton University School Of Medicine
Mayo Clin College Med
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:Arizona State
- America's Top Doctors for Cancer
- Mayo Clinic Investigator of the Year Award
- Distinguished Service Award
- Best Doctors in America
- Editor's Recognition Award
- Award for Best of Session, Poster Presentation
- Valedictorian Class of 1985
- Deans List, Six Semesters
- Superior Scholastic Achievement Award
- Lange Medical Publications Student Award, 2 Years
- Mosby Scholarship Book Award
- Adolf Sachs Award, Highest Cumulative Average
- Irving Bernstein Award in Physiology
- School of Medicine Scholarship, 2 Years
- Merck Manual Award
- Alpha Omega Alpha Medical Society
- Clinical Oncology Fellowship in Radiation Oncology
- Superior Scholastic Achievement Award For 2 years
Education
-
Mayo School of Graduate Medical Education -
Creighton University School of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota -
Mayo Clinic - Phoenix/Scottsdale, Arizona
Drug Facts
| NPI NUMBER | 1396728820 | |
| NPPES Provider LastName | SCHILD | |
| NPPES Provider FirstName | STEVEN | |
| NPPES Provider ZIPCode | 852595404 | |
| NPPES Provider State | AZ | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 31.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1396728820 |
| Last Name Of The Provider | SCHILD |
| First Name Of The Provider | STEVEN |
| View All |
Similar Doctors
|
|
Dr. William W. Wong, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Anushka H. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sameer R. Keole, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William G. Rule, MD |
|
Dr. Diane C. Recine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sujay A. Vora, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michele Y. Halyard, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael D. Sapozink, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Steven E. Finkelstein, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Vershalee Shukla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven E. Finkelstein, MD |
|
|
Dr. Howard J. Morris, MD
This Doctor is OpenDoctor Recommended.
|